The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Dogs as a Model for Cancer
Open accessAbstract
Spontaneous cancers in client-owned dogs closely recapitulate their human counterparts with respect to clinical presentation, histological features, molecular profiles, and response and resistance to therapy, as well as the evolution of drug-resistant metastases. In several instances the incorporation of dogs with cancer into the preclinical development path of cancer therapeutics has influenced outcome by helping to establish pharmacokinetic/pharmacodynamics relationships, dose/regimen, expected clinical toxicities, and ultimately the potential for biologic activity. As our understanding regarding the molecular drivers of canine cancers has improved, unique opportunities have emerged to leverage this spontaneous model to better guide cancer drug development so that therapies likely to fail are eliminated earlier and therapies with true potential are optimized prior to human studies. Both pets and people benefit from this approach, as it provides dogs with access to cutting-edge cancer treatments and helps to insure that people are given treatments more likely to succeed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Dogs with naturally occurring cancers are emerging as valuable translational models [119–121]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Genome sequence, comparative analysis and haplotype structure of the domestic dog
members, B. S. P., Lindblad-Toh, K., Wade, C. M., Mikkelsen, T. S., Karlsson, E. K., Jaffe, D. B., Kamal, M., Clamp, M., Chang, J. L., Kulbokas, E. J., et al. (2005) · Nature · doi:10.1038/nature04338 · Cited by 2,568
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
Byrd, J. C., Furman, R. R., Coutre, S. E., Flinn, I. W., Burger, J. A., Blum, K. A., Grant, B., Sharman, J. P., Coleman, M., Wierda, W. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215637 · Cited by 2,270
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306220 · Cited by 1,685
Advani, R. H., Buggy, J. J., Sharman, J. P., Smith, S. M., Boyd, T. E., Grant, B., Kolibaba, K. S., Furman, R. R., Rodriguez, S., Chang, B. Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7906 · Cited by 1,128
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752
Determinants of BRAF Mutations in Primary Melanomas
Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg123 · Cited by 664
Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression
Paoloni, M., Davis, S., Lana, S., Withrow, S., Sangiorgi, L., Picci, P., Hewitt, S., Triche, T., Meltzer, P., & Khanna, C. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-625 · Cited by 291
Shiels, M. S., Engels, E. A., Linet, M. S., Clarke, C. A., Li, J., Hall, H. I., Hartge, P., & Morton, L. M. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0040 · Cited by 112
Research works printed but not linked: 141
- Dorn CR, 1968, J. Natl. Cancer Inst., 40, 307
- 10.1111/j.1748-5827.2002.tb00066.x · DOI
- 10.1177/030098587801500602 · DOI
- Lengerich EJ, 1992, J. Am. Vet. Med. Assoc., 200, 51, 10.2460/javma.1992.200.01.51 · DOI
- Bronson RT, 1982, Am. J. Vet. Res., 43, 2057, 10.2460/ajvr.1982.43.11.2057 · DOI
- 10.1158/0008-5472.CAN-04-4613 · DOI
- 7. Reid-Smith RJ, Bonnett BN, Martin SW, Kruth SA, Abrams-Ogg A, Hazlett MJ. 2000. The incidence of neoplasia in the canine and feline patient populations of private veterinary practices in southern Ontario.Proc. 9th Sympos. Int. Soc. Vet. Epidemiol. Econ., Breckenridge, CO
- 10.1111/j.1939-1676.2008.0133.x · DOI
- 10.1093/oxfordjournals.epirev.a017981 · DOI
- 10.1177/0300985810379428 · DOI
- Withrow SJ, 2013, Withrow and MacEwen's Small Animal Clinical Oncology
- 10.1038/nrc2273 · DOI · Paper page
- 10.1093/ilar/ilu009 · DOI · Paper page
- Innes JRM, 1946, Br. Vet. J., 102, 389
- Brick JO, 1968, J. Am. Vet. Med. Assoc., 153, 47
- Thomas ED, 1993, Nobel Lectures, Physiology or Medicine 1981–1990, 576
- 10.1002/1097-0142(197711)40:5<2102::AID-CNCR2820400519>3.0.CO;2-E · DOI
- 10.1111/j.1749-6632.1976.tb41709.x · DOI
- LaRue SM, 1989, J. Am. Vet. Med. Assoc., 195, 1734, 10.2460/javma.1989.195.12.1734 · DOI
- 10.1371/journal.pmed.1000161 · DOI
- 10.1101/gr.3736605 · DOI
- 10.1101/gr.3147604 · DOI
- 24. Arendt ML, Melin M, Tonomura N, Koltookian M, Courtay-Cahen C, et al. 2015. Genome-wide association study of Golden Retrievers identifies germ-line risk factors predisposing to mast cell tumours.PLOS Genet.11(11):e1005647 · DOI
- 10.1248/bpb.35.408 · DOI
- 10.1016/j.lfs.2007.02.037 · DOI
- 10.1016/j.bone.2011.05.008 · DOI
- 10.1186/gb-2013-14-12-r132 · DOI
- 10.1016/j.bone.2010.06.011 · DOI
- 10.1002/jbmr.1708 · DOI
- 10.1093/jhered/esp039 · DOI
- 10.1186/1471-2407-11-201 · DOI
- 10.1158/1055-9965.EPI-12-0190-T · DOI
- 10.1371/journal.pgen.1003409 · DOI
- 10.1038/ng.394 · DOI
- 10.1038/ng.393 · DOI
- 10.3109/10425179709020890 · DOI
- 10.1111/j.1532-950X.2008.00407.x · DOI
- 10.1016/S0304-3835(96)04529-6 · DOI
- Mendoza S, 1998, Anticancer Res., 18, 4449
- 10.1002/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3 · DOI
- Toguchida J, 1992, Cancer Res., 52, 6194
- 10.1016/S0165-4608(03)00105-5 · DOI
- 10.1007/s10577-009-9028-z · DOI
- 10.1200/JCO.1996.14.2.467 · DOI
- Wadayama B, 1994, Cancer Res., 54, 3042
- Buettner R, 2002, Clin. Cancer Res., 8, 945
- 10.1186/1471-2407-9-81 · DOI
- 10.1186/1471-2407-7-111 · DOI
- Ryu K, 2010, J. Orthop. Res., 28, 971, 10.1002/jor.21088 · DOI
- 10.1007/s10637-011-9645-1 · DOI
- 10.1038/nrd4088 · DOI
- 10.1593/neo.91196 · DOI
- 10.1186/1746-6148-8-244 · DOI
- 10.1186/1471-2407-11-112 · DOI
- 10.1016/j.ejca.2003.11.031 · DOI
- 10.1111/j.1476-5810.2004.00047.x · DOI
- 10.1016/j.vetimm.2008.05.009 · DOI
- 10.1007/978-1-62703-170-7_2 · DOI
- 10.1007/s10577-007-1212-4 · DOI
- 10.3109/10428194.2011.559802 · DOI
- 10.1371/journal.pone.0111817 · DOI
- 10.1038/35000501 · DOI · Paper page
- 10.1177/0300985812465325 · DOI
- 10.1158/0008-5472.CAN-12-3546 · DOI
- 10.1073/pnas.180316097 · DOI
- 10.1371/journal.pone.0072591 · DOI
- 10.1158/1078-0432.CCR-10-3310 · DOI
- 10.1371/journal.pone.0095404 · DOI
- 10.1182/blood-2014-10-602714 · DOI
- 10.1111/j.1939-165X.2008.00099.x · DOI
- 10.1111/j.1476-5829.2009.00189.x · DOI
- 10.1016/j.leukres.2007.06.002 · DOI
- 10.1056/NEJM200012283432602 · DOI
- 10.1182/blood-2004-08-3097 · DOI
- 10.1111/j.1939-165X.2010.00277.x · DOI
- 10.1111/j.1939-165X.2012.00450.x · DOI
- 10.1182/blood-2002-02-0492 · DOI
- 10.1016/j.exphem.2008.09.005 · DOI
- 10.1186/1471-2407-11-38 · DOI
- 10.1093/ilar/ilu018 · DOI
- 10.1111/j.1748-5827.1996.tb01745.x · DOI
- 10.1007/BF00686255 · DOI
- Mohammed SI, 2002, Cancer Res., 62, 356
- 10.1111/j.1939-1676.1994.tb03232.x · DOI
- 10.1158/1535-7163.MCT-10-0049 · DOI
- 10.1158/1541-7786.MCR-14-0689 · DOI
- 10.1016/j.molmed.2011.02.004 · DOI
- 10.1200/JCO.2002.07.154 · DOI
- 10.1200/JCO.2003.10.033 · DOI
- 10.1093/jhered/esi122 · DOI
- 10.1056/NEJMra041866 · DOI
- 10.1186/1746-6148-5-27 · DOI
- 10.1093/jnci/91.1.73 · DOI
- 10.1126/science.279.5350.577 · DOI
- Gregory-Bryson E, 2010, BMC Immunol., 10, 559
- 10.1126/science.1079666 · DOI
- 10.1200/JCO.2003.04.190 · DOI
- 10.1186/1746-6148-9-1 · DOI
- 10.1038/35021093 · DOI
- 10.1038/srep00227 · DOI
- 10.1186/bcr2635 · DOI
- 10.1158/0008-5472.CAN-09-1725 · DOI
- 10.1186/1471-2164-10-135 · DOI
- 10.1177/0300985810363904 · DOI
- 10.1097/GCO.0b013e328012980a · DOI
- 10.1007/s00428-008-0644-3 · DOI
- 10.1016/j.tvjl.2007.10.013 · DOI
- 10.1023/A:1024929730165 · DOI
- 10.1354/vp.39-6-651 · DOI
- 10.1158/1078-0432.CCR-08-0575 · DOI
- 10.1016/j.tvjl.2012.09.005 · DOI
- 10.1200/JCO.2011.41.2452 · DOI
- 10.1111/vco.12044 · DOI
- 10.1007/s00335-004-2441-x · DOI
- 10.1038/sj.jid.5700026 · DOI
- 10.1016/S1090-0233(02)00245-9 · DOI
- 10.1093/jnci/81.12.935 · DOI
- Kurzman ID, 1995, Clin. Cancer Res., 1, 1595
- 10.1200/JCO.2005.06.031 · DOI
- 10.1158/1078-0432.CCR-08-1860 · DOI
- Mendel DB, 2003, Clin. Cancer Res., 9, 327
- Pryer NK, 2003, Clin. Cancer Res., 9, 5729
- London CA, 2003, Clin. Cancer Res., 9, 2755
- 10.1056/NEJMoa065044 · DOI
- 10.1016/S0140-6736(06)69446-4 · DOI
- 10.1073/pnas.1004594107 · DOI · Paper page
- 10.1038/nature08638 · DOI
- 10.1172/JCI4004 · DOI
- Bergman PJ, 2003, Clin. Cancer Res., 9, 1284
- Liao JCF, 2006, Cancer Immun., 6, 8
- Nguyen KT, 2012, Int. J. Biochem. Mol. Biol., 3, 137
- 10.1016/j.bcp.2011.12.016 · DOI
- 10.1371/journal.pone.0087585 · DOI
- 10.1007/s12272-012-1101-z · DOI
- 10.1002/ijc.24660 · DOI
- 10.1371/journal.pone.0027018 · DOI
- 10.1158/1078-0432.CCR-12-3381 · DOI
- 10.1200/JCO.2006.09.0803 · DOI · Paper page
- 10.1158/1078-0432.CCR-11-1001 · DOI
- 10.1158/1078-0432.CCR-09-0719 · DOI
- 10.1371/journal.pone.0124889 · DOI
Cited by
Sorted by citations
Phage therapy in oncology: opportunities for cancer prevention and treatment
Mutalik, V. K., Inman, J. L., Chang, H., Arkin, A., & Mao, J.-H. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.02.001 · Cited by 7
Metadata
- Authors
- Gardner, H. L., Fenger, J. M., & London, C. A.
- Affiliations
- Department of Veterinary Clinical Sciences and
- The Ohio State University (US)
- Venue
- Annual Review of Animal Biosciences
- Publisher
- Annual Reviews
- Published
- 2016-02-15
- Volume
- 4
- Issue
- 1
- Pages
- 199-222
- ISSN
- 2165-8102 (ISSN-L)
- 2165-8110
- PMC
- PMC6314649
- OpenAlex
- W1894349587
- Cited by
- 215
- References
- 9
- Citations by year
- 2026: 22 · 2025: 27 · 2024: 29 · 2023: 25 · 2022: 25 · 2021: 24 · 2020: 22 · 2019: 17 · 2018: 11 · 2017: 10 · 2016: 3
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Animal Biosciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (K01OD019923)
- Topics
- Health Sciences › Veterinary › Small Animals › Veterinary Oncology Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Human-Animal Interaction Studies
- Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
- Keywords
- canine cancer, dogs as cancer models, spontaneous tumors, preclinical drug development, pharmacokinetics, pharmacodynamics, drug resistance, metastasis, clinical toxicity, companion animal oncology
- MeSH terms
- Animals, Animals, Newborn, Antineoplastic Agents, Disease Models, Animal, Dog Diseases, Dogs, Humans, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dogs as a Model for Cancer. https://app.cochat.ai/papers/10.1146/annurev-animal-022114-110911
- The paper
- Gardner, H. L., Fenger, J. M., & London, C. A. (2016). Dogs as a Model for Cancer. Annual Review of Animal Biosciences. https://doi.org/10.1146/annurev-animal-022114-110911